C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2674347
The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.
L'invention se rapporte à des formes cristallines de l'ilaprazole racémique, le 2[[(4-méthoxy-3-méthyl-2-pyridinyl)-méthyl]sulfinyl]-5-(1H-pyrrol-1-yl) 1H-Benzimidazole. L'invention se rapporte également à une composition pharmaceutique pour inhiber la sécrétion d'acide gastrique comprenant une forme cristalline de l'ilaprazole selon l'invention en une quantité efficace pour inhiber la sécrétion d'acide gastrique et un véhicule pharmaceutiquement acceptable. L'invention concerne également des procédés de traitement pour divers troubles gastrointestinaux liés aux acides (GI).
Brackett John M.
Jonaitis David T.
Lai Wei
Liu Jih Hua
Parent Stephan D.
Dennison Associates
Il Yang Pharmaceutical Company Ltd.
LandOfFree
Solid state forms of racemic ilaprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid state forms of racemic ilaprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid state forms of racemic ilaprazole will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2075212